Please login to the form below

Not currently logged in
Email:
Password:

PwC says that Asia will become 'largest pharma market

According to a PricewaterhouseCoopers (PwC) report, competition among Asian countries to attract international pharmaceutical players is intensifying as governments are now offering various incentives.

According to a PricewaterhouseCoopers (PwC) report, competition among Asian countries to attract international pharmaceutical players is intensifying as governments are now offering various incentives.

It adds, however, that in spite of improvements in government regulation and intellectual property (IP) protection in the region, risk still remains relatively high.

Dan Bartholomew, senior managing director of PwC's pharmaceutical and life sciences practice, said: "The pendulum for the pharmaceutical industry is shifting from the West to the East. This means that if US-based companies want to have part of that market, they are going to need to be present in the region and learn to navigate the risks."

The report was compiled from the results of survey of 185 senior pharmaceutical executives from 92 domestic Asian companies, and 93 multinational companies with operations in nine different countries: China, India, Malaysia, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.

The MAICPS says that the fall in US export revenue was due to the 90 per cent fall in US prices for three generic drugs made by Teva after their 180-day exclusivity periods expired.

17th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics